Clinical trial · Observational
Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to understand how the protein CD81 affects myeloid leukemia (especially AML) and whether it can help predict patient outcomes or guide treatment. The main question it aims to answer: Is high CD81 expression in myeloid leukemia cells linked to more aggressive disease, poorer treatment response, or shorter survival in patients? Participants: * Newly diagnosed myeloid leukemia patients (primary focus on AML) * Bone marrow or blood samples will be collected during routine diagnostic procedures
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Acute Myeloid Leukemia | Acute Myeloid Leukemia | CURATED_BROADER | 0.80 |
| Chronic Myeloid Leukemia | Chronic Myeloid Leukemia, BCR-ABL1 Positive | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- study group
- description
- patients with myeloid leukemia
Primary outcomes (1)
- measure
- expression of CD81 in patients with myeloid leukemia
- timeFrame
- baseline
- description
- percentage of expression of CD81 in myeloid leukemia
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 1\. Myeloid leukemia patients 2. Patients of both genders (Males and females) at any age 3. Cases are de novo (Not on treatment) Exclusion Criteria: * . Patients with other haematological neoplasms (ALL,CLL, plasma cell myeloma, etc) * Patients under any therapeutic intervention * Patients with current or previous other malignancies at time of diagnosis
References
Publications (0)
Data not yet available